Dipòsit Digital de Documents de la UAB 7 registres trobats  La cerca s'ha fet en 0.02 segons. 
1.
9 p, 193.1 KB Genetic characterization of Mycobacterium tuberculosis complex isolates circulating in Abuja, Nigeria / Molina-Moya, Barbara (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Abdurrahman, Saddiq T. (National TB, Buruli Ulcer and Leprosy Control Programme, Abuja, Nigeria) ; Madukaji, Laura I (Bingham University, Nasarawa State, Nigeria) ; Gomgnimbou, Michel Kiréopori (Centre Muraz, Bobo-Dioulasso, Burkina Faso) ; Spinasse, Lizania (Université Paris Sud. Institut for Integrative Biology of the Cell) ; Gomes Fernandes, Meissiner (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Gomes, Harrison Magdinier (Université Paris Sud. Institut for Integrative Biology of the Cell) ; Kacimi, Sarah (Université Paris Sud. Institut for Integrative Biology of the Cell) ; Dacombe, Russell (Liverpool School of Tropical Medicine, Liverpool, UK) ; Bimba, John S. (Bingham University, Nasarawa State, Nigeria) ; Lawson, Lovett (Bingham University, Nasarawa State, Nigeria) ; Sola, Christophe (Université Paris Sud. Institut for Integrative Biology of the Cell) ; Cuevas, Luis E. (Liverpool School of Tropical Medicine, Liverpool, UK) ; Domínguez, José (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Universitat Autònoma de Barcelona
Nigeria ranks fourth among the high tuberculosis (TB) burden countries. This study describes the prevalence of drug resistance and the genetic diversity of Mycobacterium tuberculosis in Abuja's Federal Capital Territory. [...]
2018 - 10.2147/IDR.S166986
Infection and drug resistance, Vol. 11 (october 2018) , p. 1617-1625  
2.
4 p, 511.4 KB Extremely high levels of vancomycin can cause severe renal toxicity / Barceló-Vidal, Jaime (Parc de Salut MAR de Barcelona) ; Rodríguez-García, Eva (Parc de Salut MAR de Barcelona) ; Grau, Santiago (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia)
Vancomycin has usually been associated with nephrotoxicity. Generally, this toxicity is presented as proximal tubular cells injury with or without necrosis and as acute interstitial nephritis. However, development of both lesions is uncommonly described in literature. [...]
2018 - 10.2147/IDR.S171669
Infection and drug resistance, Vol. 11 (july 2018) , p. 1027-1030  
3.
15 p, 369.4 KB Ceftolozane/tazobactam for the treatment of complicated intra-abdominal and urinary tract infections : current perspectives and place in therapy / Escolà-Vergé, Laura (Hospital Universitari Vall d'Hebron) ; Pigrau, Carlos (Hospital Universitari Vall d'Hebron) ; Almirante Gragera, Benito (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona
The current prevalence of infections caused by multidrug-resistant (MDR) organisms is a global threat, and thus, the development of new antimicrobial agents with activity against these pathogens is a healthcare priority. [...]
2019 - 10.2147/IDR.S180905
Infection and drug resistance, Vol. 12 (2019) , p. 1853-1867  
4.
9 p, 1.3 MB Whole-genome characterization and resistance-associated substitutions in a new HCV genotype 1 subtype / von Massow, Georg (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Garcia-Cehic, Damir (Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas) ; Gregori i Font, Josep (Roche Diagnostics S.L) ; Rodriguez-Frias, Francisco (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Macià, María Dolores (Institut d'Investigació Sanitària Illes Balears) ; Escarda, Ana (Hospital Universitari Son Espases (Palma de Mallorca, Balears)) ; Esteban Mur, Juan Ignacio (Universitat Autònoma de Barcelona. Departament de Medicina) ; Quer, Josep (Universitat Autònoma de Barcelona. Departament de Medicina)
Hepatitis C virus (HCV) is a highly variable infectious agent, classified into 8 genotypes and 86 subtypes. Our laboratory has implemented an in-house developed high-resolution HCV subtyping method based on next-generation sequencing (NGS) for error-free classification of the virus using phylogenetic analysis and analysis of genetic distances in sequences from patient samples compared to reference sequences. [...]
2019 - 10.2147/IDR.S195441
Infection and drug resistance, Vol. 12 (2019) , p. 947-955  
5.
4 p, 131.8 KB Baseline hepatitis C virus resistance-associated substitutions present at frequencies lower than 15% may be clinically significant / Perales, Celia (Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas) ; Chen, Qian (Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas) ; Soria, Maria Eugenia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Gregori i Font, Josep (Roche Diagnostics SL) ; Garcia-Cehic, D. (Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas) ; Nieto-Aponte, Leonardo (Liver Pathology Unit, Department of Biochemistry and Microbiology, HUVH, Barcelona, Spain) ; Castells, Lluís (Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas) ; Imaz, Arkaitz (Hospital Universitari de Bellvitge) ; Llorens-Revull, Meritxell (Hospital Universitari Vall d'Hebron) ; Domingo, Esteban (Centro de Biología Molecular Severo Ochoa) ; Buti, Maria (Universitat Autònoma de Barcelona. Departament de Medicina) ; Esteban Mur, Juan Ignacio (Universitat Autònoma de Barcelona. Departament de Medicina) ; Rodríguez Frías, Francisco (Universitat Autònoma de Barcelona. Departament de Medicina) ; Quer, Josep (Universitat Autònoma de Barcelona. Departament de Medicina)
Controversy is ongoing about whether a minority mutant present at frequencies below 15% may be clinically relevant and should be considered to guide treatment. Resistance-associated substitution (RAS) studies were performed in patients before and at failure of antiviral treatments using Next-generation hepatitis C virus (HCV) sequencing (NGS). [...]
2018 - 10.2147/IDR.S172226
Infection and drug resistance, Vol. 11 (november 2018) , p. 2207-2210  
6.
12 p, 692.1 KB Pseudomonas aeruginosa ventilator-associated pneumonia management / Ramírez-Estrada, Sergio (Hospital Universitari Vall d'Hebron) ; Borgatta Barzé, Bárbara (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Rello, Jordi (Universitat Autònoma de Barcelona. Departament de Medicina)
Ventilator-associated pneumonia is the most common infection in intensive care unit patients associated with high morbidity rates and elevated economic costs; Pseudomonas aeruginosa is one of the most frequent bacteria linked with this entity, with a high attributable mortality despite adequate treatment that is increased in the presence of multiresistant strains, a situation that is becoming more common in intensive care units. [...]
2016 - 10.2147/IDR.S50669
Infection and drug resistance, Vol. 9 (january 2016) , p. 7-18  
7.
11 p, 215.6 KB Management of refractory Pseudomonas aeruginosa infection in cystic fibrosis / Sordé, Roger (Hospital Universitari Vall d'Hebron) ; Pahissa, Albert (Hospital Universitari Vall d'Hebron) ; Rello, Jordi (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona
Cystic fibrosis (CF) is the most common life-limiting inherited disease in Caucasian populations. The main cause of death in CF patients is respiratory failure resulting from chronic pulmonary infection. [...]
2011 - 10.2147/IDR.S16263
Infection and drug resistance, Vol. 4 (january 2011) , p. 31-41  

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.